A detailed history of Ah Equity Partners Lsv Ii, L.L.C. transactions in Erasca, Inc. stock. As of the latest transaction made, Ah Equity Partners Lsv Ii, L.L.C. holds 312,500 shares of ERAS stock, worth $912,500. This represents 0.64% of its overall portfolio holdings.

Number of Shares
312,500
Previous 312,500 -0.0%
Holding current value
$912,500
Previous $862,000 28.65%
% of portfolio
0.64%
Previous 0.89%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$12.51 - $22.75 $3.91 Million - $7.11 Million
312,500 New
312,500 $4.87 Million

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $357M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Ah Equity Partners Lsv Ii, L.L.C. Portfolio

Follow Ah Equity Partners Lsv Ii, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ah Equity Partners Lsv Ii, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Ah Equity Partners Lsv Ii, L.L.C. with notifications on news.